share_log

OneMedNet Network Expands With New Partnership With Large Academic Research Medical Center to Benefit Its Life Science Company Clients

OneMedNet Network Expands With New Partnership With Large Academic Research Medical Center to Benefit Its Life Science Company Clients

OneMedNet Network 与大型学术研究医疗中心建立了新的合作伙伴关系,以使其生命科学公司的客户受益
Accesswire ·  2023/11/09 16:15

~ Partnership To Leverage Real World Data for Life Science Innovation Accelerating New Diagnostic and Treatment Solutions ~

~ 合作利用现实世界的数据进行生命科学创新,加速新的诊断和治疗解决方案 ~

MINNEAPOLIS, MN / ACCESSWIRE / November 9, 2023 / OneMedNet Corporation (Nasdaq:ONMD) ("OneMedNet"), the leading curator of regulatory-grade imaging Real World Data ("RWD"), today announced a new partnership with a leading research medical center to accelerate and expand development of new diagnostic and treatment solutions using OneMedNet's iRWD. Life Science innovators, including pharmaceutical, AI, medical device, and clinical research organizations, are now able to effectively use existing real world data for discovery, development, regulatory-approval, and post-market surveillance.

明尼苏达州明尼阿波利斯/ACCESSWIRE /2023 年 11 监管级成像真实世界数据(“RWD”)的领先策展人OnemedNet Corporation(纳斯达克股票代码:onMD)(“OnemedNet”)今天宣布与一家领先的研究医学中心建立新的合作伙伴关系,以加速和扩大使用OnemedNet的iRWD的新诊断和治疗解决方案的开发。生命科学创新者,包括制药、人工智能、医疗设备和临床研究组织,现在能够有效地使用现有的现实世界数据进行发现、开发、监管批准和上市后监测。

"This is great news for OneMedNet who is committed to providing our Life Science company clients with access to the critical RWD they need to succeed. The challenge for Life Science companies is not the utilization of RWD in their processes, but obtaining the highly specific data that unequivocally meets all of their required data attributes," said Aaron Green, OneMedNet President. "We've been safely and securely identifying, indexing and de-identifying imaging data for well over a decade. OneMedNet's leadership in providing the most current regulatory grade data has proven invaluable to both healthcare providers and Life Sciences."

“对于致力于为我们的生命科学公司的客户提供获得成功所需的关键 RWD 的途径的 OneMedNet 来说,这是个好消息。OneMedNet总裁亚伦·格林说,生命科学公司面临的挑战不是在流程中使用RWD,而是获得明确符合其所有必要数据属性的高度具体的数据。“十多年来,我们一直在安全地识别、索引和取消识别成像数据。事实证明,OneMedNet在提供最新监管等级数据方面的领导地位对医疗保健提供商和生命科学都非常宝贵。”

This essential data which fuels technology and clinical advancement can sit idle and unproductive without healthcare providers engagement. Importantly, academic tertiary centers also offer significant data diversity which is a high priority for the Food and Drug Administration when reviewing regulatory submissions.

如果没有医疗保健提供者的参与,这些推动技术和临床进步的基本数据可能会处于闲置状态,生产力低下。重要的是,高等教育中心还提供了显著的数据多样性,这是美国食品药品监督管理局在审查监管申报时的重中之重。

The OneMedNet iRWD network consists of over 200 healthcare systems and providers. The addition of this tertiary medical center expands OneMedNet's carefully compiled RWD to 20 research centers and institutions. The main hospital is ranked in the top 40 nationwide and features one of the leading cancer centers. Given that oncology RWD is of highest demand, this represents a significant OneMedNet network addition.

OneMedNet iRWD 网络由 200 多个医疗保健系统和提供商组成。这个三级医疗中心的加入将OneMedNet精心编制的RWD扩展到20个研究中心和机构。该主要医院位列全国前40名,拥有领先的癌症中心之一。鉴于肿瘤学 RWD 的需求最高,这意味着 OneMedNet 网络的显著增加。

About OneMedNet Corporation

关于 OnemedNet 公司

Founded in 2009, OneMedNet provides innovative solutions that unlock the significant value contained within the clinical image archives of healthcare providers. Employing its proven OneMedNet iRWD solution, OneMedNet securely de-identifies, searches, and curates a data archive locally, bringing a wealth of internal and third-party research opportunities to providers. By leveraging this extensive federated provider network, together with industry leading technology and in-house clinical expertise, OneMedNet successfully meets the most rigorous RWD Life Science requirements. For more information, please visit .

OneMedNet成立于2009年,提供创新的解决方案,释放医疗保健提供者临床图像档案中包含的巨大价值。OneMedNet 采用其久经考验的 OneMedNet iRWD 解决方案,可在本地安全地进行去身份识别、搜索和整理数据档案,为提供商带来丰富的内部和第三方研究机会。通过利用这个广泛的联合提供商网络,以及行业领先的技术和内部临床专业知识,OneMedNet成功地满足了最严格的 RWD 生命科学要求。欲了解更多信息,请访问。

Investor Contact:

投资者联系人:

Shannon Devine
MZ Group North America
203-741-8811
ONMD@mzgroup.us

香农迪瓦恩
MZ 集团北美
203-741-8811
ONMD@mzgroup.us

SOURCE: OneMedNet

来源: OneMedNet


View source version on accesswire.com:
在 accesswire.com 上查看源代码版本:

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发